Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer

NCT02817126 · Fudan University · Updated 22 March 2022

What is being tested
Robot-assisted resection; Laparoscopic resection
For
Rectal Carcinoma
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 1,240 people. The full rules are on the registry page.
Where
China (11 sites)
When
Starts or started 10 July 2016, ends 31 Dec 2023. Registered 29 June 2016.
Results
None posted yet.

In the researchers' words

The purpose of this study is to evaluate the safety and oncological feasibility of robot-assisted surgery for mid/low rectal carcinoma compared with laparoscopic surgery.
ClinicalTrials.gov, NCT02817126

Sites

  • Chinese PLA General HospitalBeijing, Beijing Municipality, China
  • The Southwest Hospital of Army Medical UniversityChongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Zhengzhou UniversityZhengzhou, Henan, China
  • The First Affiliated Hospital of Nanchang UniversityNanchang, Jiangxi, China
  • Jilin Cancer HospitalChangchun, Jilin, China
  • Chinese PLA General Hospital of Northern Theatre Command (former Shenyang Military General Hospital)Shenyang, Liaoning, China
  • The 960th Hospital of Chinese PLA Joint Logistic Support Force (former Jinan Military General Hospital)Jinan, Shandong, China
  • The Affiliated Hospital of Qingdao UniversityQingdao, Shandong, China
  • Ruijin Hospital, Shanghai Jiaotong University School of MedicineShanghai, Shanghai Municipality, China
  • Zhongshan Hospital, Fudan UniversityShanghai, Shanghai Municipality, China
  • The First Affiliated Hospital of Naval Medical University (Changhai Hospital)Shanghai, Shanghai Municipality, China